Market News
Stay updated with the latest market trends, earnings, and economic indicators.
INR settles lower as global crude oil prices stay elevated amid Middle East turmoil
The Indian rupee depreciated 15 paise to close at 95.34 (provisional) against the US dollar on Tuesday, as global crude oil prices jumped and the American currency remained firm amid massive safe-haven inflows. Significant foreign fund outflows also weighed on the investor sentiments. At the interbank foreign exchange market, the rupee opened at 95.16 against the US dollar, then touched an intraday high of 95.03 and a low of 95.37. Indian shares closed higher on Tuesday, staging a rebound after four days of losses as investors assessed mixed signals over the status of U.S.-Iran peace talks and awaited upcoming RBI rate decision. The Nifty 50 gained 100.95 points (0.43%) to close at 23,483.55, while the Sensex rose 382.50 points (0.52%) to settle at 74,649.84.

Bitcoin falls to two-month low as Strategy sale, West Asia risks weigh
Bitcoin fell to its lowest level since early April after top corporate holder Strategy sold a portion of its holdings and escalating West Asia tensions dampened risk appetite. Continued ETF outflows and uncertainty over US-Iran relations further pressured the cryptocurrency market.

Rupee edges lower against dollar amid oil price concerns, FPI outflows
Indian rupee opens weaker at 95.06 against US dollar as high crude prices and foreign fund outflows weigh on sentiment, RBI steps in to curb volatility.

Expert view: Can't say the worst is behind for markets; positive on banks, says Mittul Kalawadia of ICICI Prudential AMC
Mittul Kalawadia, Senior Fund Manager at ICICI Prudential AMC, emphasises the importance of flexible investment strategies and identifies banking and specific discretionary sectors as attractive opportunities amidst ongoing volatility.

RBI clears Mirae Asset MF to raise stake in Equitas SFB up to 9.5%
The RBI has approved Mirae Asset Mutual Fund to acquire an aggregate holding of up to 9.5% in Equitas Small Finance Bank. The approval is valid for one year and is subject to compliance with banking and securities regulations.

Forget Equity Research? Radhika Gupta Lists The Real High-Growth Jobs In Finance
File image of Edelweiss Mutual Fund MD and CEO Radhika Gupta
14 penny stocks plunge up to 55% in 2 months. Are you affected?
​Fourteen penny stocks have declined sharply over the past two months, with losses of up to 55%, highlighting the risks associated with low-priced equities. While such stocks attract investors seeking quick gains, weak liquidity, volatility and governance concerns make them highly vulnerable to sharp corrections and capital erosion.​
Midcaps in a sweet spot? Why Nippon India’s Rupesh Patel sees a valuation correction despite new index peaks
Nippon India Mutual Fund's Rupesh Patel remains constructive on midcaps despite concerns over valuations, citing resilient earnings growth and improved valuation comfort after a prolonged time correction. He favours financials, consumer discretionary and select industrials, while emphasising a bottom-up stock-picking approach to navigate geopolitical and macroeconomic uncertainties.
F&O Talk: Nifty may stay range-bound; Sudeep Shah sees opportunities in banks, IT, picks 7 stocks
Indian stock markets experienced a sharp selloff on Friday, with Sensex and Nifty dropping over 1%, driven by passive fund flows from MSCI index reshuffles. Volatility surged as the market lost Rs 6 lakh crore in capitalization. Analysts suggest caution amid indecisiveness and a lack of strong directional momentum.
Bond market at a turning point! Axis Mutual Fund says bond investors should buy, not panic
Axis MF cautions that aggressive rate hikes won't address INR depreciation and may harm India's growth. They recommend a neutral-to-slightly long duration stance over three months, adjusting based on RBI policy and crude prices, while advising gradual exposure to fixed-income assets.
PB Fintech sees Rs 665 crore block deal as founders pare stake; Goldman among other top funds buy
PB Fintech founders Yashish Dahiya and Alok Bansal sold 38 lakh shares worth Rs 665 crore in a block deal. The shares were purchased by various institutional investors, including Goldman Sachs and Tata Mutual Fund, following the company's recent performance.
Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listing
Bio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading at a discount. The Rs 52 crore IPO, which saw overall subscription of 2.26 times, aims to fund loan repayment and manufacturing expansion. Despite selective institutional interest, investor caution prevails due to broader market volatility.